<sup>11</sup>C-METPET在脑肿瘤中的应用

华逢春

¹¹C-METPET在脑肿瘤中的应用

华逢春

文章导航 > 国际放射医学核医学杂志 > 2002, 26 > 1: (1-4)

引用本文:

Citation:

¹¹C-METPET在脑肿瘤中的应用

华逢春

200040 上海, 复旦大学附属华山医院核医学科

作者简介: 华逢春(1973-),男,安徽安庆人,硕士研究生,主要从事PET的临床应用。;

中图分类号: R817.4

The applications of ¹¹C-MET PET in brain tumor

HUA Feng-chun

Department of Nuclear Medicine, Huashan Hospital, Fudan University, Shanhai 200040, China
CLC number: R817.4

摘要: ¹¹C-MET(¹¹C-蛋氨酸)是目前用于肿瘤PET最多的氨基酸类显像剂之一,它能反映体内氨基酸的转运、肿瘤氨基酸的代谢及蛋白质的合成。¹¹C-MET PET能用于脑肿瘤的诊断、区分肿瘤复发及放射性坏死,早期评价治疗效果,尤其对肿瘤周边组织及低度恶性肿瘤的诊断要优于¹⁸F-FDG PET、CT和MRI。
- 脑肿瘤 /
- 正电子发射断层显像 /
- ¹¹C-蛋氨酸
Abstract: ¹¹C-methionine (MET), an amino acid, is the most widely used radiopharmaceutics which can reflect transport metabolism of amino acid in vivo, and synthesis of protein in tumor.¹¹C-METPET can be used for evaluation of brain tumor:detection of tumor, differential diagnosis between recurrence and radiation necrosis and early evaluation of response to treatment.Especially, for the definition of tumor margin and detection of low-grade tumors, PET with ¹¹C-MET is better than PET with ¹⁸F-FDG or other modalities such as CT and MRI.
- brain tumor /
- positron emission tomography /
- ¹¹C-methion
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Weber WA, Wester Hi, Grosu AL, et al. O-(2-[¹⁸F] Flourothyl)-L-tyrosine and L-[methyl ¹¹] methionine uptake in brain tumours:initial results of a comparative study[J]. Eur J Nucl Med, 2000, 27(5):542-549.
[2]	Matheja P, Schober O.¹²³I-IMT SPET:introducing another research tool into clinical neuro-oncology[J]. Eur J Nucl Med, 2001, 28(1):1-4.
[3]	Roelcke U, Radu E, Ametamey S, et al. Association of rubidium and ¹¹C-methionine uptake in braintumors measured by positron emission tomography[J]. J Neurooncol, 1996, 27(2):163-167.
[4]	Jager PL, Vaalburg W, Pruim J, et al. Radiolabeledamino acids:basic aspects and clinical appacations in ontology[J]. J Nucl Med, 2001, 42(3):432-445.
[5]	Derlon JM, Chapon F, Noel MH, et al. Non-invasive grading of oligodendrogliomas:correlations between in vivo metabolic pattern and histopathology[J]. Eur J Nucl Med, 2000, 27(7):778-787.
[6]	Derlon JM, Petit-Taboue MC, Chapon F, et al.The in vivo metabolic pattern of low-grade brain gliomas:a positron emission tomographic study using ¹⁸F-fluorodeoxyglucose and ¹¹C-L-methylmethionine[J]. Neurosurgery, 1997, 40(2):276-288
[7]	Goldman S, Levivier M, Pirotte B, et al. Regional methionine and glucose uptake in high-grade gliomas:a comparative study on PET-guided stereotactic biopsy[J]. J Nucl Med, 1997, 38(9):1459-1462.
[8]	Sato N, Suzuki M, Kuwata N, et al. Evaluation of the malignancy of glioma using ¹¹-methionine positron emission tomography and proliferating cell nuclear antigen staining[J]. Neurosurg Rev, 1999, 22(4):210-214.
[9]	Sasaki M, Kuwabara Y, Yoshida T, et al. A comparative study of thallium-201 SPET, carbon-11 methionine PET and fluorine-18 fluoodeoxyglucose PET for the differentiation of astrocytic tumours[J]. Eur J Nucl Med, 1998, 25(9):1261-1269.
[10]	Nyberg G, Bergstrom M, Enblad P, et al. PET-methionine of skull base neuromas and meningiomas[J]. Acta Otolaryngol (Stockh), 1997, 117:482-489.
[11]	Braga FJHN, Flamen P, Van Calenbergn F. 11-Cmethionine (MET) and 18-FDG PET for the evaluation of suspected recurrent brain tumours(SRBT)[J]. Eur J Nucl Med, 2000, 27(8):1145.
[12]	Kaschten B, Stevenaert A, Sadzot B, et al. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxy-glucose and/or carbon-11-methionine[J]. J Nucl Med, 1998, 39(5):778-785.
[13]	Nuutinen J, Sonninen P, Leiikoinen P, et al. Radiotherapy treatment planning and long-term follow-up with[¹¹C] methionine PET in patients with low-grade astrocytoma[J]. Int J Radiat Oncol Biol Phys, 2000,48(1):43-52.
[14]	Roelcke U, Ammom KV, Hausmann O, et al. Operated low grade astrocytomas:a long term PET study on the effect of radiotherapy[J]. J Neurol Neurosury Psychiatry, 1999, 66:644-647.
[15]	Gudjonsson O, Blomquist E, Lilja A, et al. Evaluation of the effect of high-energy proton irradiation treatment on meningiomas by means of ¹¹C-L-methionine PET[J]. Eur J Nucl Med, 2000,27(12):1793-1799.
[16]	Voges J, Herholz K, Holzer T, et al. ¹¹-methionine and ¹⁸F-2-fluorodeoxyglucose position emission tomogrphy:a tool for diagnosis of cerebral glioma and monitoring after brachytherapy with ¹²⁵I seeds[J]. Stereotaet Funet Nurosurg, 1997, 69(1-4pt2):129-135.
[17]	Tsuyuguchi N, Sunada I, Iwai Y, et al. Investigation of false positive and false negative signs in methionine-PET[J]. Riv Neuroradiol, 1998,11(suppl 2):87-90.
[18]	Tashima T, Moriaka T, Nishio S, et al. Delayed cerebral radionecrosis with a high uptake of ¹¹-methionine on positron emission tomography and 201Tl-chloride on single-photon emission computed tomography[J]. Neuroradiology, 1998,40:435-438.

[1]	陈立波 . 用于肿瘤代谢显像的几种放射性标记氨基酸. 国际放射医学核医学杂志, 2002, 26(1): 18-20.
[2]	赵晋华 , 林祥通 . 显示脑肿瘤活力的四种SPECT显像剂. 国际放射医学核医学杂志, 1996, 20(2): 53-57.
[3]	周惠君 , 董萍 , 沈国华 , 李林 . ¹¹C-蛋氨酸PET/CT显像在脑胶质瘤中的应用价值. 国际放射医学核医学杂志, 2015, 39(2): 161-164. doi: 10.3760/cma.j.issn.1673-4114.2015.02.013
[4]	唐刚华 . 基因表达正电子发射断层显像. 国际放射医学核医学杂志, 2001, 25(6): 241-245.
[5]	杨晓诚 , 胡怀湘 , 霍力 . 放射性标记氨基酸的肿瘤基础研究. 国际放射医学核医学杂志, 2003, 27(1): 25-27.
[6]	李林 . ¹⁸F-FDG PET显像在肿瘤学中的应用. 国际放射医学核医学杂志, 2000, 24(6): 254-258.
[7]	罗全勇 . 除FDG以外的用于肿瘤PET显像的¹⁸F标记物. 国际放射医学核医学杂志, 2001, 25(6): 249-253.
[8]	李亚军 , 白人驹 , 高硕 , 李彦生 , 刘磊 , 贾薇 , 蔡莉 , 邢喜玲 . 兔VX2肺肿瘤PET-CT与血管生成的相关性研究. 国际放射医学核医学杂志, 2010, 34(3): 139-142. doi: 10.3760/cma.j.issn.1673-4114.2010.03.003
[9]	潘越 , 王观筠 , 党浩丹 , 徐白萱 . RGD肽类示踪剂及其PET显像在脑胶质瘤诊疗中的应用. 国际放射医学核医学杂志, 2023, 47(6): 362-366. doi: 10.3760/cma.j.cn121381-202207012-00299
[10]	陈艳芳 , 杨天恩 , 曹永珍 . 放射性脑损伤和脑肿瘤复发的鉴别诊断. 国际放射医学核医学杂志, 2006, 30(5): 308-311.
[11]	黄喆敏 , 左传涛 , 管一晖 . ¹⁸F-氟脱氧葡萄糖的脑肿瘤PET. 国际放射医学核医学杂志, 2007, 31(3): 163-165,172.

点击查看大图

计量

文章访问数: 1114
HTML全文浏览量: 114
PDF下载量: 2

¹¹C-METPET在脑肿瘤中的应用

华逢春

作者简介:华逢春(1973-),男,安徽安庆人,硕士研究生,主要从事PET的临床应用。

200040 上海, 复旦大学附属华山医院核医学科

收稿日期: 2001-06-27

关键词:

摘要: ¹¹C-MET(¹¹C-蛋氨酸)是目前用于肿瘤PET最多的氨基酸类显像剂之一,它能反映体内氨基酸的转运、肿瘤氨基酸的代谢及蛋白质的合成。¹¹C-MET PET能用于脑肿瘤的诊断、区分肿瘤复发及放射性坏死,早期评价治疗效果,尤其对肿瘤周边组织及低度恶性肿瘤的诊断要优于¹⁸F-FDG PET、CT和MRI。